Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
Fractional CO2 Laser Therapy for Survivors of Gynecologic Malignancies
Sponsor: Ohio State University Comprehensive Cancer Center
This NA trial investigates Cervical Carcinoma and Dyspareunia and is currently completed. Ohio State University Comprehensive Cancer Center leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2021 — May 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Jun 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — May 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .